Back to Agenda
Enhancing the Science of Patient Engagement and Patient Input: What's in the Future?
Session Chair(s)
Pujita Vaidya, MPH
Director, Regulatory Science and Policy, Sanofi, United States
This forum discussion focuses on current state, challenges, and opportunities to enhancing the science of patient input. Panel of experts will discuss examples of approaches with partnering with patients, enanging regulators and measuring progress.
Learning Objective : Discuss approaches and best practices for partnering and co-creating with patients; Identify strategies to systematically incorporate patient input into decision making; Describe opportunities to enhance interactions between industry and regulators; Discuss approaches to measure progress in engaging patients and its impact to medical product development.
Speaker(s)
Robyn Bent, BSN, MS, RN
Director, Patient Focused Drug Development, OCD, CDER, FDA, United States
FDA Perspective
Elizabeth Lange, MPH, MS
VP & Head, RQC, Science, Policy & Intelligence (SPI), Novo Nordisk A/S, United States
Industry Perspective and Case Example
Bellinda King-Kallimanis, PHD, MSC
Senior Director of Patient-Focused Research , Lungevity Foundation, United States
Patient Researcher Perspective
Have an account?